$DLB

Pendleton Todd sold $648K of DLB

Pendleton Todd (SVP, Chief Marketing Officer) sold 11,876 shares of Dolby Laboratories, Inc. (DLB) at $54.55 ($0.65M total) on 2026-05-22.

Original reporting
SEC EDGAR · Pendleton Todd
Published May 27, 2026, 9:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 27, 2026, 9:15 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$DLB
Neutral
high confidence
Mentioned
$DLB
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$DLBNeutralLow
01

Why it matters

Insider sale disclosures can modestly influence short-term sentiment, but without accompanying company catalysts they rarely drive sustained repricing.

02

Market read

Traders may monitor for sentiment/positioning signals, but the disclosure alone is unlikely to change valuation assumptions.

03

What to watch

No 10b5-1 plan is cited; however, absence of a plan in the snippet doesn’t establish intent, and the article provides no follow-on context (e.g., earnings proximity, performance-based vesting).

Relevance 6/10Timing: Same-day/next-session attention possible, but typically fades quickly for routine Form 4 sales.

Background

The article is an SEC Form 4 insider transaction filing (open-market sale) for Dolby Laboratories shares by a named executive.

Company-level read

Ticker impact

$DLBNeutralHigh confidence
Context

Dolby Laboratories insider Pendleton Todd (SVP, Chief Marketing Officer) sold 11,876 shares in an open-market transaction disclosed on Form 4.

Expected impact

Likely limited near-term impact; any move would be more sentiment/flow-driven than fundamentals.

Evidence & confidence

The filing is an open-market sale with no 10b5-1 plan stated and no accompanying company-specific news (earnings, guidance, deal, or regulatory action).

Market effects

Minimal; insider transactions generally do not reset sector expectations without linked operational or guidance changes.

None indicated; disclosure is company-specific and not tied to broader regional demand/supply shocks.

None indicated; no international contract, trial, or regulatory development mentioned.

Counterpoint

The sale could reflect diversification or tax/liquidity needs and may not imply negative views on Dolby’s prospects.

Key entities

  • Dolby Laboratories, Inc.

    Subject of the Form 4 insider sale by SVP/Chief Marketing Officer Pendleton Todd.

  • Pendleton Todd

    SVP, Chief Marketing Officer who sold 11,876 shares at ~$54.5518 on 2026-05-22.

Related articles

$DLBMed

Dolby Laboratories, Inc. Q3 2026 Earnings Call Summary

Dolby Laboratories’ Q3 2026 earnings call said it is shifting toward content platforms and usage-based revenue, targeting 10% of total revenue from partners by FY2028. Management cited traction for its Video Distribution Program, including Meta and Alibaba deals, and a China-first automotive strategy. Q4 guidance calls for 23% YoY revenue growth, with a $4M restructuring charge and a $350M share repurchase authorization increase.

$DLBMed

Why Dolby Labs Stock Popped Today

Dolby Laboratories (NYSE: DLB) shares rose 11.7% by 10:45 a.m. ET after its fiscal Q3 2026 results. The company reported revenue of $305 million versus an estimated $312 million, and EPS of $0.69 versus $0.67 expected. GAAP EPS was $0.30. Dolby guided Q4 sales to $362 million-$392 million and full-year revenue to at least $1.4 billion.

$DLBMedAI 8/10

Dolby (DLB) Q3 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Peter L. Goldmacher Chief Executive Officer - Kevin J. Yeaman Chief Financial Officer - Robert J. Park TAKEAWAYS Revenue -- $305 million, falling within management guidance ranges despite timing-related impacts in foundational audio. Non-GAAP EPS -- $0.69, exceeding the midpoint of guidance as lower operating expenses helped offset revenue shifts.

$DLBMed

Dolby Laboratories (NYSE:DLB) Misses Q2 CY2026 Sales Expectations

Audio and video technology company Dolby Laboratories (NYSE: DLB) missed Wall Street’s revenue expectations in Q2 CY2026, with sales falling 3.3% year on year to $305 million. On the other hand, next quarter’s outlook exceeded expectations with revenue guided to $377 million at the midpoint, or 7.4% above analysts’ estimates. Its non-GAAP profit of $0.69 per share was 3% above analysts’ consensus estimates. Is now the time to buy Dolby Laboratories?

$DLBHighAI 9/10

Dolby Laboratories Reports Third Quarter 2026 Financial Results

Copyright 2026 PR Newswire. All Rights Reserved 2026-07-30 SAN FRANCISCO, July 30, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the third quarter of fiscal 2026. "We continue to execute against our full-year objectives, and we are building momentum across several of our key growth areas," said Kevin Yeaman, President and CEO, Dolby Laboratories.

$DLBHigh

Dolby Laboratories, Inc. (DLB): Results of Operations and Financial Condition

Dolby Laboratories, Inc. (DLB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d165402dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Dolby Laboratories Reports Third Quarter 2026 Financial Results SAN FRANCISCO, July 30, 2026 — Dolby Laboratories, Inc. (NYSE:DLB) today announced the company’s financial results for the third quarter of fiscal 2026. “We co